Precigen
Afreen Sayed is a Scientist in In vivo pharmacology at Precigen since January 2022. Prior to this role, Afreen Sayed worked as a Postdoctoral Researcher at the University of Kansas Medical Center from June 2020 to January 2022. Educationally, Afreen Sayed earned a degree from the University of Kansas Medical Center between 2014 and 2019.
This person is not in any offices
Precigen
3 followers
Precigen is a biopharmaceutical company advancing the next generation of gene and cellular therapies.